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Patients with pemphigus vulgaris (PV) have circulating anti-desmoglein (Dsg) 3 immunoglobulin G (IgG) autoan-
tibodies that induce blister formation. We developed an in vitro quantitative assay to evaluate the pathogenic
strength of anti-Dsg3 IgG autoantibodies in blister formation. To obtain intercellular adhesion mediated dominantly
by Dsg3, we used primary cultured normal human keratinocytes expressing low level of Dsg2 in the presence of
exfoliative toxin A that specifically digests Dsg1. After incubation with various antibodies, monolayers released by
dispase were subjected to mechanical stress by pipetting, and the number of cell fragments were counted. When
anti-Dsg3 monoclonal antibodies (mAb) obtained from pemphigus model mice were tested, pathogenic AK23 mAb
yielded significantly higher number of cell fragments than AK7 or AK20 non-pathogenic mAb. Dissociation scores,
deﬁned with AK23 mAb as the positive control, were significantly higher with active stage PV sera (n¼ 10,
77.4  21.4) than controls (n¼ 11, 16.0  9.6; p¼ 0.003). When pair sera obtained from 6 PV patients in active stage
and in remission were compared, the dissociation scores reﬂected well the disease activity as those in active stage
were four to 17 times higher than those in remission. When sera from different patients showing similar ELISA
scores but different clinical severity were tested (n¼ 6), the dissociation scores with sera from severe disease
activity were significantly higher than those with sera in remission. These ﬁndings indicate that this dissociation
assay will provide a simple and objective biological method to measure the pathogenic strength of pemphigus
autoantibodies.
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Pemphigus vulgaris (PV) is an autoimmune disease char-
acterized by suprabasal blisters on the skin and mucous
membrane. Without appropriate treatment, the disease can
become severe or even fatal because of loss of the epider-
mal barrier function, leading to loss of body fluids or sec-
ondary infection (Amagai, 2003). Patients with PV have
circulating immunoglobulin G (IgG) autoantibodies directed
against desmoglein (Dsg) 3, a transmembrane desmosomal
glycoprotein that belongs to the cadherin class of calcium-
dependent adhesion molecules (Amagai et al, 1991). Com-
pelling evidence indicates that autoantibodies in PV play a
primary pathogenic role in blister formation (Anhalt et al,
1982; Amagai et al, 1992; 1994).
Indirect immunofluorescence and/or ELISA are widely
used to measure titers of circulating IgG autoantibodies in
PV. There is a general correlation between titers of PV au-
toantibodies and disease activity when monitored in indi-
vidual patients (Beutner et al, 1985; Ishii et al, 1997; Cheng
et al, 2002). But, we sometimes see patients with severe
disease despite low titers of anti-Dsg3 autoantibodies. Fur-
thermore, some PV cases with high titers of anti-Dsg3 au-
toantibodies exhibit mild disease severity (Harman et al,
2001). Thus, ELISA scores do not necessarily provide ab-
solute values for the disease severity, probably because
ELISA detects simply the immunoreactivity of anti-Dsg3 IgG
autoantibodies and does not directly measure the patho-
genic activity in disruption of intercellular adhesion of
keratinocytes.
It is well known that autoantibodies in patients with pe-
mphigus are polyclonal (Futei et al, 2000; Sekiguchi et al,
2001). Recently, Tsunoda et al (2003) isolated several mouse
monoclonal anti-Dsg3 antibodies from PV model mice and
demonstrated that there is pathogenic heterogeneity among
the anti-Dsg3 monoclonal antibodies (mAb). Some antibod-
ies have potency of blistering inducing activity in vivo. On
the other hand, for other anti-Dsg3 antibodies, the in vivo
binding of IgG to Dsg3 is not sufficient to cause blistering.
Together with the discrepancy between disease severity
and autoantibody titers in some cases with PV, it is as-
sumed that there is pathogenic heterogeneity of IgG sera
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among different pemphigus patients. That is, IgG autoan-
tibodies in pemphigus sera may contain both sets of path-
ogenic and non-pathogenic autoantibodies. Therefore, it is
important to assess the pathogenicity of pemphigus IgG
autoantibodies to elucidate the molecular mechanism of
blister formation in pemphigus.
A passive transfer of PV sera to neonatal mice is a well-
established assay to assess the pathogenic ability to induce
bullous formation of PV sera (Anhalt et al, 1982). In the as-
say, injection of concentrated IgG prepared from PV sera to
neonatal mice can induce blisters on the neonatal skin. This
assay, however, requires a large volume of sera to induce
blister formation in the skin of mice. In addition, although a
subjective scaling (0–4) of the extent of the blister formation
can be used (Mahoney et al, 1999), the assay does not
detect the pathogenic strength in a quantitative manner. To
compare pathogenic strength among pemphigus sera, a
more sensitive assay to detect pathogenic activity needs to
be developed.
In this paper, we developed an in vitro dissociation assay
using primary human epidermal keratinocytes to measure
the pathogenic activity of anti-Dsg3 autoantibodies in PV
sera. The assay not only showed the difference of patho-
genic strength among PV sera with similar ELISA scores but
also provided a valuable tool to dissect molecular mecha-
nisms for the heterogeneity in the pathogenic strength of
pemphigus autoantibodies.
Results
Expression pattern of Dsg isoform varies among kera-
tinocytes Dsg consists of four isoforms, Dsg1–4 (Getsios
et al, 2004). There is evidence that Dsg1 and Dsg3 have
compensatory functions in intercellular adhesion when they
are co-expressed in the same cells in vivo (Mahoney et al,
1999; Wu et al, 2000). To detect specific disruption of inter-
cellular adhesion by anti-Dsg3 antibody, ideal cells would be
the ones that express predominantly Dsg3 without co-ex-
pression of other Dsg isoforms. To address this issue, we first
characterized the expression pattern of Dsg isoforms in var-
ious cultured cells. KU8 cells derived from penile squamous
cell carcinoma (SCC) and A431 cells derived from vulva
squamous carcinoma mainly expressed Dsg2, whereas they
expressed Dsg3 at a low level and no detectable Dsg1
(Fig 1). The predominant expression of Dsg2 is also known in
other cultured epithelial cell lines, such as HaCaT keratin-
ocytes, SCC lines, MDCK, or A431 cells (Schafer et al, 1994;
Denning et al, 1998; Ishii et al, 2001). In contrast, primary
cultured normal human epidermal keratinocytes (NHK) ex-
press predominantly Dsg3 and Dsg1 with minimal expression
of Dsg2 (Fig 1). The shift in Ca2þ concentration of culture
medium to 1.2 mM did not change the predominant expres-
sion of Dsg1 and Dsg3 in NHK cells (Fig 1).
To further eliminate the Dsg1 expression, we used
staphyloccocal exotoxin, exfoliative toxin A (ETA), which
specifically digests Dsg1 as a serine protease (Amagai et al,
2000). The treatment of NHK cells with 0.5 mg per mL of ETA
for 2 h was sufficient to eliminate most of the expression of
Dsg1 (Fig 1). Thus, NHK cells in the presence of ETA will
provide cells predominantly expressing Dsg3.
Dsg3 dominant cell–cell adhesion is obtained by NHK
cells in the presence of ETA To evaluate the intercellular
adhesion of keratinocytes, we developed in vitro dissocia-
tion assay with modification of a previously described sim-
ilar assay (Calautti et al, 1998; Caldelari et al, 2001; Huen
et al, 2002). NHK cells cultured in 1.2 mM calcium contain-
ing medium were incubated with various antibodies or sera.
Keratinocyte sheets released by dispase were subjected to
a mechanical stress by pippeting.
When NHK cells were incubated without any antibodies,
the cell sheet was well maintained even after the physical
stress by pipetting (Fig 2A). Then we tested the effect of
anti-Dsg3 mAb, AK23, which was obtained from PV model
mice and proved to be pathogenic and capable of inducing
blister formation in mice (Tsunoda et al, 2003). When NHK
cells were incubated with AK23 mAb alone, the cell sheet
was fragmented but only at a minimal level (Fig 2B). When
NHK cells were incubated with ETA alone, the cell sheet
was fragmented, but again only at a minimal level (Fig 2C).
But, when NHK cells were incubated together with AK23
mAb and ETA, the cell sheet was broken into numerous
smaller pieces (Fig 2D). Therefore, cell–cell adhesion of
NHK cells in our culture condition is mediated by Dsg1 and
Dsg3, which are compensating each other. These findings
indicate that Dsg3-dominant cell–cell adhesion was ob-
tained by NHK cells in the presence of ETA.
In addition, when we used HaCaT cells under similar
conditions instead of NHK, incubation of AK23 mAb and
ETA together did not induce a significant dissociation (data
not shown). This illustrates the importance of using cells
that express a low level of Dsg2 in this assay.
Figure1
Expression pattern of desmoglein (Dsg) isoforms in cultured hu-
man epidermal keratinocytes. Normal human epidermal keratin-
ocytes (NHK) were cultured to confluence in low-calcium medium and
switched into 1.2 mM calcium-containing medium at 4, 9, or 24 h be-
fore harvest. In the exfoliative toxin A (ETA) lane, NHK were incubated
with 0.5 mg per mL of ETA for 2 h after being cultured in high-calcium
medium for 24 h. KU8 (squamous carcinoma cell line) and A431 (vulvar
carcinoma cells) were also included. Total cell lysates were separated
by 7.5% SDS-PAGE and subjected to immunoblot with antibodies
against Dsg1 (982), Dsg2 (6D8), and Dsg3 (5H10). Note that NHK ex-
press Dsg3 and Dsg1 predominantly whereas KU8, and A431 cells
express Dsg2 mainly.
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We could not evaluate the expression of Dsg4 (Kljuic
et al, 2003; Whittock and Bower, 2003) because of unavail-
ability of appropriate antibodies. But, the finding that the
inactivation of Dsg3 by AK23 mAb and Dsg1 by ETA was
sufficient to disrupt the cell–cell adhesion of NHK cells
suggested that Dsg4 is either not expressed or, if ex-
pressed, Dsg4 may not play a significant role in cell adhe-
sion at least in NHK cells.
Dissociation assay can detect pathogenic strength of
anti-Dsg3 antibodies in disruption of intercellular adhe-
sion To determine whether the dissociation assay using
NHK cells was capable of evaluating different pathogenic
activities among anti-Dsg3 IgG antibodies, we used AK se-
ries of mouse anti-Dsg3 mAb obtained from PV model mice
(Tsunoda et al, 2003). The pathogenic activities of AK mAb
had been determined by two in vivo assays: passive trans-
fer using neonatal mice, and ascites formation using adult
mice (Tsunoda et al, 2003). AK7 mAb does not cross-react
with human Dsg3. AK20 mAb cross-reacts with human
Dsg3, but does not induce apparent blisters by passive
transfer assay or ascites formation assay. AK23 mAb, as
mentioned above, induces blisters in the both assays.
Although cell sheets incubated with AK23 mAb were
dissociated into numerous smaller fragments after a me-
chanical stress, cell sheets incubated with AK7 or AK20
mAb exhibited minimal dissociation as seen in untreated
cell sheets (Fig 3A). The number of cell fragments revealed
that AK23 mAb dissociated cell sheets 4.6–5.4-fold more
than AK7 mAb. The number of cell particles treated with
AK20 mAb was approximately the same as that of AK7
mAb, even though AK20 mAb has immunoreactivity against
human Dsg3 (Fig 3B). In addition, shown in Fig 3C, the
number of cell particles increased as the concentration of
AK23 increased, indicating that this assay can detect path-
ogenic strength in a quantitative manner.
Thus, the dissociation assay using NHK cells in the
presence of ETA could demonstrate the difference in the
pathogenic activity among mouse anti-Dsg3 mAb.
Dissociation scores in PV were significantly higher than
those of normal controls Next, we determined whether
this assay reflects the pathogenic activity of human sera
from PV patients. Ten sera from patients with PV in active
stage and 11 normal individuals were analyzed by the dis-
sociation assay (Fig 4). Of these 10 PV sera, five samples
Figure 2
Treatment with combination of a pathogenic AK23 anti-desmoglein
(Dsg) 3 monoclonal antibody and exfoliative toxin A (ETA)-disso-
ciated cell sheets of normal human epidermal keratinocytes (NHK).
Monolayers of NHK were treated with either AK23 monoclonal anti-
Dsg3 antibody (1 mg per mL) overnight (B), ETA (1 mg per mL) for 2 h (C),
or a combination of both reagents (D). Dissociation assay was per-
formed as described in the Material and Methods section. Note that cell
sheets were minimally dissociated when treated with only AK23 or ETA,
whereas the cell sheets broke into numerous small fragments when
treated with both AK23 and ETA. Numbers indicate a mean of numbers
of fragments counted by image pro software using three captured
images.
Figure 3
Dissociation assay to detect the path-
ogenic strength of anti-desmoglein
(Dsg) 3 antibodies in disruption of inter-
cellular adhesion. (A) Monolayers of nor-
mal human epidermal keratinocytes were
treated with various monoclonal anti-
Dsg3 antibodies. After 2 h incubation
with 0.5 mg per mL of exfoliative toxin A,
monolayers were separated from culture
dishes by incubation with dispase. Sub-
sequently, they were subjected to me-
chanical stress by pipetting using 1 mL of
pipetman five times. AK7 does not have
cross-reactivity with human Dsg3 and
was used as a negative control. AK20
has reactivity against human Dsg3, but
failed to induce apparent blisters by pas-
sive transfer to neonatal mice. AK23 has
reactivity against human Dsg3 and has a
pathogenic activity shown by passive
transfer to neonatal mice. (B) Quantifica-
tion was obtained by counting the number
of fragments of cell sheets as described in
the Material and Methods section. (C) The
cell sheets were incubated with AK23 at
concentrations of 0.1, 0.5, 1, and 5 mg per
mL. Each condition was in duplicate. Bars
represent standard deviations.
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have anti-Dsg1 in addition to anti-Dsg3 antibodies. Conflu-
ent NHK sheets were incubated with the sera at a dilution of
1:5 for 24 h and treated with ETA for the last 2 h, and sub-
sequently subjected to the dissociation assay. The disso-
ciation scores were used to normalize interassay variability
using the number of fragmented particles obtained by AK23
mAb as a positive control. A cut-off value was defined as
the average value plus 2 SD of normal control sera. The
mean of normal control sera was 16.0  9.6, resulting in
35.2 as a cut-off value. None of the normal control sera fell
above the cut-off value, whereas all of pemphigus sera
exceeded the cut-off value. The dissociation scores with
pemphigus sera range from 47.3 to 116.4 (mean 
SD¼ 77.4  21.4), which is significantly higher than those
of normal control sera (Mann–Whitney U test, p¼0.003).
These results suggest that this assay provides a tool to
quantify the pathogenic strength of patients’ sera in disrup-
tion of cell–cell adhesion.
When the PV sera samples were analyzed without ETA
treatment, the dissociation scores of most samples were
negative (Fig 4). The two PV sera that remained positive
contained both anti-Dsg3 and anti-Dsg1 autoantibodies.
Some PV sera contain anti-Dsg1 IgG autoantibodies,
whereas others do not. Thus, the inactivation of Dsg1 by
ETA is essential to determine the sole pathogenic strength
of anti-Dsg3 IgG autoantibodies by eliminating the effects
on dissociation of anti-Dsg1 IgG autoantibodies.
Dissociation scores correlate well with the clinical dis-
ease activity in PV We then determined whether the dis-
sociation scores correlate well with the clinical disease
activity in PV. We examined serum samples both during an
active stage and in remission, which were obtained from
two patients with mucocuaneous-type PV and four patients
with mucosal dominant-type PV (Table I and Fig 5). The
samples were analyzed by Dsg3 and Dsg1 ELISA as well.
Figure 4
Dissociation assay to detect pathogenic activity in disruption of
intercellular adhesion of pemphigus vulgaris (PV) sera. Ten sera
patients with PV in active stage (five sera that have only anti-des-
moglein (Dsg) 3 autoantibody (open circle) and five sera that have both
Dsg3 and Dsg1 autoantibodies (filled dot)) and 11 sera from normal
healthy controls were examined by the dissociation assay treated with
and without exfoliative toxin A (ETA). A dashed line indicates a cut-off
value, defined as an average plus 2 SD of normal control sera. Bars
indicate averages of each group of samples. The dissociation scores of
PV sera were significantly higher than that of normal controls (Mann–
Whitney U test, p¼ 0.003). In the assay without treatment of ETA, the
dissociation scores for PV sera were negative except two samples,
which contain Dsg1 in addition to Dsg3 autoantibodies.
Table I. Correlation of dissociation scores and clinical disease severity in PV
Age (y) Sex Diagnosis
Clinical disease
activity Duration
ELISA
Dissociation
scores Initial treatmentDsg3 Dsg1
Pt. 1 40 Male PV-mc Severe 3 y 1515.9 57.9 106.0 PSL 60 mg per dþplasmapheresis
Remission 32.4 0.3 6.0
Pt. 2 63 Male PV-mc Severe 5 mo 369.1 7.6 72.9 Methylprednisolone pulseþ
Remission 29.7 0 18.2 PSL 60 mg per d
Pt. 3 33 Male PV-m Severe 4 mo 514.9 1.2 180.0 PSL 60 mgþplasmapheresis
Remission 73.2 0.1 30.0
Pt. 4 47 Female PV-m Severe 10 mo 2553.7 4.8 111.1 PSL 40 mg per d
Remission 5.7 0.3 28.7
Pt. 5 35 Female PV-m Severe 2 y 443.3 1.9 143.4 Topical steroid application
Remission 415.8 2.5 31.0
Pt. 6 52 Male PV-m Severe 1 y 77.8 6.8 129.1 PSL 60 mg per d
Remission 111 0.1 14.3
PV-mc and PV-m indicate mucocutaneous type pemphigus vulgaris and mucosal dominant type pemphigus vulgaris, respectively.
Age is at patient’s first presentation at hospital.
Dsg3 ELISA indicates the value obtained by multiplying the index value by dilution factor.
Dsg, desmoglein.
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In Pt. 1–4, Dsg3 ELISA scores were high at active stages
and decreased in remission. In these patients, the dissoci-
ation scores also reflected the disease activity and showed
high scores (72–180) at active stage and low scores (6–30)
in remission. ELISA scores, however, sometimes fail to re-
flect the disease activity as seen in Pt. 5 and 6. In these
patients, the ELISA scores in remission were about the
same or even slightly higher than at active stages. Interest-
ingly, even in these patients, the dissociation scores prop-
erly reflected the disease activity and showed high scores
(143, 129) at the active stage and low scores (31, 14) in
remission. Thus, the dissociation assay properly reflects the
clinical disease activity within single patients.
Dissociation assay properly evaluates the disease ac-
tivity among different patients with similar ELISA
scores We finally examined whether the dissociation as-
say detects a pathogenic heterogeneity among PV sera
from different patients. To address this, we selected serum
samples from six PV patients who had similar Dsg3 ELISA
scores but different disease activity (Fig 6). The ELISA index
values of these six samples were approximately 100; three
of them were from patients in the active stage, and three
were from patients in remission. Despite the similar ELISA
scores, the dissociation assay showed high scores (112–
240) for those in an active stage and low scores for those in
remission (44–82). These data suggest that this assay prop-
erly evaluates the pathogenic strength in blocking cell ad-
hesion of PV sera and may provide the absolute indicator
for the disease activity in PV.
Discussion
In this study, we developed an in vitro dissociation assay
using cultured normal human keratinocytes. To characterize
this assay, we first used a series of monoclonal anti-Dsg3
antibodies, which were isolated from pemphigus model
mice and in which pathogenic activities were well charac-
terized by means of in vivo pathogenicity assays. Patho-
genic activities assessed from this in vitro assay reported
here correlated with the data from the in vivo pathogenicity
assays, suggesting that this assay was reliable in detecting
the strength of anti-Dsg3 antibodies in disruption of inter-
cellular adhesion. Next, when 10 PV sera and 11 normal
control sera were analyzed, the dissociation scores in the
PV sera group were significantly higher than those in normal
controls, indicating that this assay can be used to measure
the pathogenicity of pemphigus sera. The dissociation
scores correlated with the disease severity in all six pa-
tients when analyzed with sera from different stages in in-
dividual patients. In addition, when we analyzed sera from
different patients with similar immunoreactivity against
Dsg3, the dissociation scores correlated well with clinical
disease activity. These findings suggest that this assay may
be useful to monitor the disease activity in pemphigus.
Although there may be a concern that pipetting cell
sheets does not give a uniform stress, we did find that
sheets without pathogenic antibodies were quite resistant to
breakage and those with pathogenic antibodies were easily
dissociated. Therefore, the amount of stress is probably not
the critical factor in how well these sheets break up, at least
within the range of stress generated by pipetting. Further-
more, dissociation by pipetting is a previously described
technique used by several groups for this assay (Calautti
et al, 1998; Caldelari et al, 2001). An alternative method for
mechanical stress is rotation or shaking of tubes containing
dispase-released cell sheets (Huen et al, 2002; Setzer et al,
2004). We found that the stress by rotation was too mild to
reproducibly induce dissociation in our condition. Therefore,
we chose pipetting to provide mechanical stress to cell
sheets and the results demonstrate that the assay, as per-
formed, does correlate well with disease activity.
Figure 5
Dissociation scores correlate well with the clinical disease severity
in pemphigus vulgaris (PV). Two mucocutaneous-type PV (Pt. 1 and 2)
and four mucosal dominant-type PV (Pt. 3–6) were studied using in vitro
dissociation assay and desmoglein (Dsg) 3 ELISA. Serum samples were
taken when patients were in an active stage and in remission. Ratio of
values to those in an active stage was shown for Dsg3 ELISA and
in vivo dissociation assay. ‘‘A’’ and ‘‘R’’ represent an active stage and
remission, respectively.
Figure6
Detection of pathogenic heterogeneity of anti-desmoglein (Dsg) 3
autoantibodies in pemphigus vulgaris (PV) sera. Serum samples
from six PV patients that have similar reactivity against Dsg3 were
examined by dissociation assay (approximately 100 index in Dsg3
ELISA). Three of these samples were collected when the patients were
in active stage. Three samples were collected when the patients were
in remission.
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This assay can detect the strength of intercellular adhe-
sion disruption only for anti-Dsg3 antibodies. This was
made possible because we used primary human keratin-
ocytes with low expression of Dsg2 and used ETA to digest
Dsg1, which results in the culture cells mainly expressing
Dsg3. It was shown that Dsg1 and Dsg3 compensate each
other in their adhesive function in epithelial cells in vivo
(Mahoney et al, 1999; Wu et al, 2000). If isoforms other than
Dsg3 were expressed in the same cells, it was assumed
that the isoforms mask the disruption effect of cell adhesion
by Dsg3 antibody. The human keratinocytes we used here
expressed both Dsg3 and Dsg1 predominantly. When ker-
atinocyte sheets were incubated only with monoclonal anti-
Dsg3 antibodies, the cell sheets were not dissociated well.
When the keratinocytes were incubated both with mono-
clonal Dsg3 antibodies and ETA, the cell sheets were dis-
sociated. This finding is further evidence to support the
hypothesis that Dsg isoforms compensate for each other in
their adhesive function.
To evaluate the disease activity of pemphigus, titers ob-
tained from indirect immunofluorescence or ELISA are cur-
rently used. In general, the titers fluctuate in parallel with
disease severity when monitored in a single individual. In
some cases, however, values of Dsg3 ELISA remain high
although the disease is clinically inactive (Harman et al,
2001). Creswell et al (1981) studied 21 cases of pemphigus
regarding the correlation of disease activity and serial titers
of indirect immunofluorescence. They found that in one
case of 21 cases, the titer remained elevated in spite of
clinical remission. Pt. 5 and 6 in Table I are examples of
such cases. Despite a high value of Dsg3 ELISA, the dis-
sociation scores in these cases were low during clinical re-
mission. This could be explained by the fact that ELISA or
immunofluorescence is a serological assay to detect bind-
ing capacity against Dsg3 by autoantibodies. Compared
with this, the dissociation assay is a biological assay to
detect the cell adhesive strength. The values from this dis-
sociation assay directly show the pathogenic strength of
autoantibodies in intercellular adhesion. This is useful for
evaluation of the disease severity for pemphigus.
We have shown that sera with the same immunoreactiv-
ity against Dsg3 have different properties in disruption of
cell adhesion (Fig 6). This demonstrates that sera have het-
erogeneous properties in blocking of intercellular adhesion.
This finding raised the question as to what the determinants
of pathogenicity of autoantibodies in pemphigus sera are.
One possible explanation as to what determines patho-
genicity of autoantibodies is epitopes that autoantibodies
bind. There is some evidence that pemphigus sera target
multiple epitopes on Dsg1 and Dsg3 molecules (Futei et al,
2000; Sekiguchi et al, 2001). Tsunoda et al isolated eight
monoclonal anti-Dsg3 antibodies that have different prop-
erties in disruption of intercellular adhesion. The epitope of
a pathogenic antibody Ak23 was mapped in the region of
the adhesive interface between juxtaposed Dsg3, whereas
the epitope of mAb that failed to induce apparent patho-
genic activity was mapped in the middle to carboxyl termi-
nal extracellular region, where no direct intermolecular
interaction was predicted. Another paper showed that
in endemic pemphigus foliaceus (FS), another type of
pemphigus characterized by anti-Dsg1 autoantibodies,
disease onset was associated with the emergence of au-
toantibodies specific for epitopes in the amino-terminal do-
main. In addition, sera from FS patients in remission
showed reactivity restricted to carboxyl terminal extracel-
lular region (Li et al, 2003). Thus, it is possible that the
binding epitopes may determine pathogenic activities. Al-
ternatively, it is possible that a combination of several au-
toantibodies against different epitopes may induce strong
pathogenicity, although a single individual autoantibody itself
does not have strong pathogenic activity. As the dissociation
assay is a simplified and sensitive test to detect pathogeni-
city of anti-Dsg3 autoantibodies, a combination of epitope
mapping and this dissociation assay would be helpful to
determine the pathogenic factor on Dsg3 molecules.
In summary, we developed a dissociation assay to detect
the pathogenic strength of Dsg3 antibodies in disruption of
intercellular adhesion. The dissociation assay provides a
useful tool to evaluate the pathogenic strength of pe-
mphigus autoantibodies. Furthermore, the evaluation of the
pathogenic strength of pemphigus autoantibodies will pro-
vide us with a better understanding for what defines the
pathogenic heterogeneity among anti-Dsg3 autoantibodies
in pemphigus.
Material and Methods
Human sera PV is subdivided into two types: mucosal dominant
type and mucocutaneous type. Mucosal-type PV have only anti-
Dsg3 autoantibodies whereas mococutaneous-type PV have anti-
Dsg3 and Dsg1 autoantibodies (Ishii et al, 1997; Amagai et al,
1999b). Sera were obtained from 10 patients with PV, whose di-
agnoses were confirmed by clinical, histologic, and immunopath-
ological findings. Of these samples, five sera had anti-Dsg1 in
addition to anti-Dsg3 autoantibodies determined by Dsg ELISA.
For analysis of correlation between disease activity and dissoci-
ation scores, serum samples were collected from another six PV
patients at active stage and in remission. Of these samples, we
included two cases with high scores of Dsg3 ELISA even in re-
mission (Pt. 5 and 6 in Table I). In addition, for analysis of path-
ogenic heterogeneity among sera from different PV patients,
another six samples with similar Dsg3 ELISA scores but different
disease activity were selected. The study was approved by the
institution review board of Keio University and was conducted ac-
cording to the Declaration of Helsinki Principles. All samples were
used with informed consent.
Antibodies AK series of mouse AK7, AK20, and AK23 mAb
against mouse and human Dsg3 were prepared as previously de-
scribed (Tsunoda et al, 2003). The following mouse mAb were used
for immunoblots: 6D8, against Dsg2 (a kind gift from Dr M. Wheel-
ock (Wahl et al, 1996)), and 5H10, against human Dsg3 (Proby et al,
2000). Serum from a patient with pemphigus follaceus was also
used to detect Dsg1.
Cell culture NHK were obtained and cultured in medium
MDCB153 as described before (Shirakata et al, 2003). KU8 cells
isolated from a penile squamous cell line, and A431 cells were
cultured in DMEM with 10% fetal bovine serum (Tsukamoto, 1989;
Ishii et al, 2001). The human naturally immortalized keratinocyte
HaCaT cell line was a kind gift from Dr Norbert Fusenig (German
Cancer Research Center, Heidelberg, Germany) and cultured in
DMEM with 10% fetal bovine serum.
Production of recombinant ETA Recombinant ETA with His tag
on the carboxyl terminal end was expressed in Escherichia coli
DH10B (Yamaguchi et al, 2002) and recovered from the soluble
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fraction in lysis buffer (20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 0.2%
Triton X-100, and protease inhibitor cocktail (Complete Mini, EDTA
free; Roche Diagnostics, Mannheim, Germany)), and purified with
TALON affinity resin (Clontech, Palo Alto, California).
Development of dispase-based dissociation assay NHK cells
were seeded onto 12-well plates and cultured in MDCB153 me-
dium containing 0.1 mM calcium. After reaching confluency, the
medium was changed to the one with 1.2 mM calcium. Various
antibodies or sera were added and incubated at 371C overnight.
Two hours before the assay, the cells were incubated with ETA at
0.5 mg per mL to cleave Dsg1 specifically (Amagai et al, 2000). After
washing with PBS twice, NHK were incubated with dispase (Roche
Diagnostics) for 15 min to release cells as monolayers. Released
monolayers were carefully washed with PBS twice and subject to
mechanical stress by pipetting with a 1 mL pipetman. Fragments
were fixed by adding formaldehyde at a final concentration of 3%
and stained by adding crystal violet (Sigma-aldrich, St Louis, Mis-
souri). The number of particles was determined as an average of
the number of cell particles counted by image pro software (Media
Cybernetics, Silver Spring, Maryland), using three sets of images
captured by a digital camera for each plate. Dissociation scores
were calculated using the number of fragmented cell sheets (N)
using the following formula: Dissociation scores¼ ((N with se-
rumN without serum)/(N with AK23N without serum))  100.
The cell sheet with AK23 at 1 mg per mL was included in each
assay to adjust for interassay variability.
Immunoblot analyses Cells were lyzed in 2  Laemmli SDS-
sample buffer and the concentration of each sample was meas-
ured by an amido black protein assay (Sheffield et al, 1987). Equal
volume of samples was size-fractionated by SDS-PAGE and trans-
ferred to an Immobilon- P membrane (Millipore, Bedford, Massa-
chusetts). Antibodies were used at the following dilutions for
immunoblots: PF serum (#982, a kind gift from Dr John R. Stanley)
against Dsg1, 1:1000; 6D8 against Dsg2, 1:1000; and 5H10 against
Dsg3, 1:1000. A peroxidase-conjugated anti-mouse IgG antibody
(Medical and Biological Laboratories, Nagoya, Japan) and a per-
oxidase-linked anti-human Ig antibody (Amersham, Uppsala, Swe-
den) were used as secondary antibodies.
Dsg3 and Dsg1 ELISA Immunoreactivity against Dsg3 and Dsg1
of IgG autoantibodies in PV sera was analyzed by Dsg3 and Dsg1
ELISA following the manufacture’s instructions (Medical and Bio-
logical Laboratories) (Ishii et al, 1997; Amagai et al, 1999a). When
the ELISA index values were greater than 150, the sera were se-
rially diluted from 1:100 to 1:1600 to determine the optimal dilution,
and the ‘‘true’’ index values were obtained by multiplying the index
values by the dilution factor (Cheng et al, 2002).
Statistics The Mann–Whitney U test was used for comparison of
dissociation scores between PV sera and normal controls.
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